List of Tables

Table 01. Classification of Beta-Lactamase Inhibitors And Its Properties
Table 02. Global Beta-Lactam And Beta Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 03. Beta-Lactam And Beta Lactamase Inhibitors Market For Penicillin, By Region, 2018-2028 ($Million)
Table 04. Beta-Lactam And Beta Lactamase Inhibitors Market For Cephalosporin, By Region, 2018-2028 ($Million)
Table 05. Beta-Lactam And Beta Lactamase Inhibitors Market For Carbapenem, By Region, 2018-2028 ($Million)
Table 06. Beta-Lactam And Beta Lactamase Inhibitors Market For Monobactam, By Region, 2018-2028 ($Million)
Table 07. Beta-Lactam And Beta Lactamase Inhibitors Market For Combination, By Type, 2018-2028 ($Million)
Table 08. Beta-Lactam And Beta Lactamase Inhibitors Market For Combination, By Region, 2018-2028 ($Million)
Table 09. Global Beta-Lactam And Beta Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 10. Beta-Lactam And Beta Lactamase Inhibitors Market For Urinary Tract Infection (Excluding Cuti), By Region, 2018-2028 ($Million)
Table 11. Beta-Lactam And Beta Lactamase Inhibitors Market For Respiratory Infection, By Region, 2018-2028 ($Million)
Table 12. Beta-Lactam And Beta Lactamase Inhibitors Market For Skin Infection, By Region, 2018-2028 ($Million)
Table 13. Beta-Lactam And Beta Lactamase Inhibitors Market For Complicated Urinary Tract Infection (Cuti), By Region, 2018-2028 ($Million)
Table 14. Number of Patients For Complicated Urinary Tract Infection (Cuti), By Country, 2018-2028 (Thousands)
Table 15. Beta-Lactam And Beta Lactamase Inhibitors Market For Complicated Intra-Abdominal Infections (Ciai), By Region, 2018-2028 ($Million)
Table 16. Number of Patients For Complicated Intra-Abdominal Infections (Ciai), By Country, 2018-2028 (Thousands)
Table 17. Beta Lactam & Beta Lactamase Inhibitors Market For Nosocomial Pneumonia, By Type, 2018-2028 ($Million)
Table 18. Beta-Lactam And Beta Lactamase Inhibitors Market For Nosocomial Pneumonia, By Region, 2018-2028 ($Million)
Table 19. Number of Patients For Nosocomial Pneumonia, By Country, 2018-2028 (Thousands)
Table 20. Beta-Lactam And Beta Lactamase Inhibitors Market For Blood Stream Infection, By Region, 2018-2028 ($Million)
Table 21. Number of Patients For Blood Stream Infection, By Country, 2018-2028 (Thousands)
Table 22. Beta-Lactam And Beta Lactamase Inhibitors Market For Other Diseases, By Region, 2018-2028 ($Million)
Table 23. Global Beta-Lactam And Beta Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 24. Beta-Lactam And Beta Lactamase Inhibitors Market For Oral, By Region, 2018-2028 ($Million)
Table 25. Beta-Lactam And Beta Lactamase Inhibitors Market For Intravenous, By Region, 2018-2028 ($Million)
Table 26. Beta-Lactam And Beta Lactamase Inhibitors Market For Others, By Region, 2018-2028 ($Million)
Table 27. Global Beta-Lactam And Beta-Lactamase Inhibitors Market Revenue, By Region, 2018-2028 ($Million)
Table 28. North America Beta-Lactam And Beta-Lactamase Inhibitors Market, By Country, 2018-2028 ($Million)
Table 29. U.S. Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 30. U.S. Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 31. U.S. Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 32. Canada Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 33. Canada Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 34. Canada Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 35. Mexico Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 36. Mexico Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 37. Mexico Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 38. North America Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 39. North America Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 40. North America Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 41. Europe Beta-Lactam And Beta-Lactamase Inhibitors Market, By Country, 2018-2028 ($Million)
Table 42. Germany Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 43. Germany Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 44. Germany Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 45. France Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 46. France Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 47. France Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 48. Spain Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 49. Spain Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 50. Spain Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 51. Italy Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 52. Italy Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 53. Italy Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 54. Uk Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 55. Uk Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 56. Uk Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 57. Rest of Europe Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 58. Rest of Europe Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 59. Rest of Europe Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 60. Europe Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 61. Europe Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 62. Europe Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 63. Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market, By Country, 2018-2028 ($Million)
Table 64. Japan Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 65. Japan Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 66. Japan Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 67. India Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 68. India Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 69. India Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 70. China Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 71. China Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 72. China Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 73. South Korea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 74. South Korea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 75. South Korea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 76. Indonesia Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 77. Indonesia Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 78. Indonesia Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 79. Thailand Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 80. Thailand Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 81. Thailand Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 82. Vietnam Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 83. Vietnam Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 84. Vietnam Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 85. Taiwan Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 86. Taiwan Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 87. Taiwan Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 88. Rest of Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 89. Rest of Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 90. Rest of Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 91. Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 92. Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 93. Asia-Pacific Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 94. Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Country, 2018-2028 ($Million)
Table 95. Brazil Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 96. Brazil Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 97. Brazil Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 98. Saudi Arabia Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 99. Saudi Arabia Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 100. Saudi Arabia Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 101. South Africa Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 102. South Africa Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 103. South Africa Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 104. Rest of Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 105. Rest of Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 106. Rest of Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 107. Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Drug Class, 2018-2028 ($Million)
Table 108. Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Disease, 2018-2028 ($Million)
Table 109. Lamea Beta-Lactam And Beta-Lactamase Inhibitors Market, By Route of Administration, 2018-2028 ($Million)
Table 110. Abbott: Company Snapshot
Table 111. Abbott: Operating Segments
Table 112. Abbott: Product Portfolio
Table 113. Allergan: Company Snapshot
Table 114. Allergan: Operating Segments
Table 115. Allergan: Product Portfolio
Table 116. Roche: Company Snapshot
Table 117. Roche: Operating Segments
Table 118. Roche: Product Portfolio
Table 119. Gsk: Company Snapshot
Table 120. Gsk: Operating Segments
Table 121. Gsk: Product Portfolio
Table 122. Merck: Company Snapshot
Table 123. Merck: Operating Segments
Table 124. Merck: Product Portfolio
Table 125. Mylan: Company Snapshot
Table 126. Mylan: Operating Segments
Table 127. Mylan: Product Portfolio
Table 128. Novartis Ag: Company Snapshot
Table 129. Novartis: Operating Segments
Table 130. Novartis Ag: Product Portfolio
Table 131. Pfizer: Company Snapshot
Table 132. Pfizer: Operating Segments
Table 133. Pfizer: Product Portfolio
Table 134. Sanofi: Company Snapshot
Table 135. Sanofi: Operating Segments
Table 136. Sanofi: Product Portfolio
Table 137. Teva: Company Snapshot
Table 138. Teva: Operating Segments
Table 139. Teva: Product Portfolio

LIST OF FIGURE

List of Figures

Figure 01. Beta-Lactam And Beta-Lactamase Inhibitors Market Segmentation
Figure 02. Top Investment Pockets In The Global Beta-Lactam And Beta-Lactamase Inhibitors Market
Figure 03. Top Winning Strategies, By Year, 2015-2019*
Figure 04. Top Winning Strategies, By Development, 2015-2019* (%)
Figure 05. Top Winning Strategies, By Company, 2015-2019*
Figure 06. Global Beta-Lactam And Beta-Lactamase Inhibitors Top Player Positioning, 2018
Figure 07. Moderate Bargaining Power of Buyers
Figure 08. High Bargaining Power of Suppliers
Figure 09. Low Threat of New Entrants
Figure 10. Moderate Threat of Substitution
Figure 11. High Competitive Rivalry
Figure 12. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Penicillin, By Country, 2018 & 2028 ($Million)
Figure 13. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Cephalosporin, By Country, 2018 & 2028 ($Million)
Figure 14. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Carbapenem, By Country, 2018 & 2028 ($Million)
Figure 15. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Monobactam, By Country, 2018 & 2028 ($Million)
Figure 16. Combination Beta-Lactam And Beta Lactamase Inhibitors Market For Penicillin/Beta Lactamase Inhibitors, 2018-2028 ($Million)
Figure 17. Combination Beta-Lactam And Beta Lactamase Inhibitors Market For Cephalosporins/Beta Lactamase Inhibitors, 2018-2028 ($Million)
Figure 18. Combination Beta-Lactam And Beta-Lactamase Inhibitors Market For Carbapenems/Beta Lactamase Inhibitors, 2018-2028 ($Million)
Figure 19. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Combination, By Country, 2018 & 2028 ($Million)
Figure 20. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Urinary Tract Infection (Excluding Cuti), By Country, 2018 & 2028 ($Million)
Figure 21. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Respiratory Infection, By Country, 2018 & 2028 ($Million)
Figure 22. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Skin Infection, By Country, 2018 & 2028 ($Million)
Figure 23. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Complicated Urinary Tract Infection (Cuti), By Country, 2018 & 2028 ($Million)
Figure 24. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Complicated Intra-Abdominal Infections (Ciai), By Country, 2018 & 2028 ($Million)
Figure 25. Hospital Acquired Pneumonia Market, 2018-2028 ($Million)
Figure 26. Ventilator Associated Pneumonia Market, 2018-2028 ($Million)
Figure 27. Other Nosocomial Pneumonia Market, 2018-2028 ($Million)
Figure 28. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Nosocomial Pneumonia, By Country, 2018 & 2028 ($Million)
Figure 29. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Blood Stream Infection, By Country, 2018 & 2028 ($Million)
Figure 30. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Other Diseases, By Country, 2018 & 2028 ($Million)
Figure 31. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Oral, By Country, 2018 & 2028 ($Million)
Figure 32. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Intravenous, By Country, 2018 & 2028 ($Million)
Figure 33. Comparative Analysis of Beta-Lactam And Beta Lactamase Inhibitors Market For Others, By Country, 2018 & 2028 ($Million)
Figure 34. Abbott: Net Sales, 2016-2018 ($Million)
Figure 35. Abbott: Revenue Share By Segment, 2018 (%)
Figure 36. Abbott: Revenue Share By Region, 2018 (%)
Figure 37. Allergan: Net Sales, 2016-2018 ($Million)
Figure 38. Allergan: Revenue Share By Segment, 2018 (%)
Figure 39. Roche: Net Sales, 2016-2018 ($Million)
Figure 40. Roche: Revenue Share By Segment, 2018 (%)
Figure 41. Roche: Revenue Share By Region, 2018 (%)
Figure 42. Gsk: Net Sales, 2016-2018 ($Million)
Figure 43. Gsk: Revenue Share By Segment, 2018 (%)
Figure 44. Gsk: Revenue Share By Region, 2018 (%)
Figure 45. Merck: Net Sales, 2016-2018 ($Million)
Figure 46. Merck: Revenue Share By Segment, 2018 (%)
Figure 47. Merck: Revenue Share By Region, 2018 (%)
Figure 48. Mylan: Net Sales, 2016-2018 ($Million)
Figure 49. Mylan: Revenue Share By Region, 2018 (%)
Figure 50. Novartis: Net Sales, 2016-2018 ($Million)
Figure 51. Novartis: Revenue Share By Segment, 2018 (%)
Figure 52. Novartis: Revenue Share By Region, 2018 (%)
Figure 53. Pfizer: Net Sales, 2016-2018 ($Million)
Figure 54. Pfizer: Revenue Share By Segment, 2018 (%)
Figure 55. Pfizer: Revenue Share By Region, 2018 (%)
Figure 56. Sanofi: Net Sales, 2016-2018 ($Million)
Figure 57. Sanofi: Revenue Share By Segment, 2018 (%)
Figure 58. Sanofi: Revenue Share By Region, 2018 (%)
Figure 59. Teva: Net Sales, 2016-2018 ($Million)
Figure 60. Teva: Revenue Share By Region, 2018 (%)